NEW YORK (GenomeWeb News) - Belgian company OncoMethylome Sciences has expanded its lab in Amsterdam by leasing an extra 1,000 square meters of lab space and hiring 10 new scientists.
The company said it expanded operations and personnel to support clinical trials for the its colorectal cancer program.
OncoMethylome is developing non-invasive molecular methylation screening tests that are performed on DNA from blood or stool samples. The research is supported by the Dutch Ministry of Economic Affairs.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

An opinion piece in the Guardian argues that President Donald Trump is uninterested in science and that might not be a bad thing for the field.

The San Francisco Chronicle reports the Veterans Affairs Health System is studying whether genetic testing can help prescribe better depression therapies.

Stat News reports that Spark Therapeutics' Luxturna is now being used to treat a wider array of patients.

In Genome Biology this week: transcription factor use among brittle stars, single-cell RNA sequencing strategy, and more.